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Abstract: One of the most widely conserved hallmarks of aging is a decline in functional 
capabilities. Mobility loss is particularly burdensome due to its association with negative 
health outcomes, loss of independence and disability, and the heavy impact on quality of life. 
Recently, a new condition, physical frailty and sarcopenia, has been proposed to define a 
critical stage in the disabling cascade. Physical frailty and sarcopenia are characterized by 
weakness, slowness, and reduced muscle mass, yet with preserved ability to move indepen-
dently. One of the strategies that have shown some benefits in combatting mobility loss and 
its consequences for older adults is physical activity. Here, we describe the opportunities and 
challenges for the development of physical activity interventions in people with physical 
frailty and sarcopenia. The aim of this article is to review age-related physio(patho)logical 
changes that impact mobility in old age and to provide recommendations and procedures in 
accordance with the available literature. 
Keywords: physical exercise, muscle mass, strength, walking, balance, better aging
Introduction
One of the major challenges rising from the aging of the population is to avoid 
mobility impairment. Mobility is defined in a broad context by Webber et al1 as the 
ability to move oneself (either independently or by using assistive devices or 
transportation) within environments that expand from one’s home to the neighbor-
hood and to regions beyond. Approximately one third to one half of individuals 
aged 65 years or older report difficulties related to walking or climbing stairs.1 
Furthermore, mobility limitation during aging is associated with loss of strength 
and/or function that characterizes sarcopenia.2–4 Sarcopenia is described by the 
EWGSOP2 as a progressive and generalized skeletal muscle disorder that is 
associated with increased likelihood of adverse outcomes including falls, fractures, 
physical disability, and mortality.5 Sarcopenia is now formally acknowledged as a 
muscle disease with an ICD-10-MC diagnosis code.6 This medical syndrome of 
sarcopenia may reflect a gradual decline that impairs functional reserve in a 
dynamic process. On a parallel track, adverse events can drastically modify the 
health status of a person, which refers to the concept of frailty. An international 
group of experts has defined frailty as a clinical state in which there is an increase in 
an individual’s vulnerability for developing increased dependency and/or mortality 
when exposed to a stressor. Frailty can occur as the result of a range of diseases and 
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medical conditions.7,8 In this context, a frail individual is 
characterized by weak functional abilities that occur large 
deterioration after a minor illness.9 In order to counteract 
the effect of the aging process and avoid moving toward a 
state of frailty, functional reserve has to be strengthened, 
notably by physical activity. Physical activity is used as an 
umbrella term including exercise, leisure time physical 
activity, or even sports.10 Physical activity is defined as 
any bodily movement produced by skeletal muscles that 
require energy expenditure, whereas exercise is a planned, 
structured, repetitive movement including progression 
with regard to intensity.10
Frailty, especially associated with sarcopenia syn-
drome, is the main pivotal point to establish a preventive 
intervention program. Actually, there is evidence that 
without intervention, sarcopenia and frailty often lead to 
disability, falls, and a decline in quality of life.11 There is 
also an increased risk of hospitalization and death.7,8 That 
is why prevention of loss of mobility becomes a priority in 
this population.
Regular physical activity, exercise, and leisure time 
physical activity including sports, combined with an 
adequate diet can prevent sarcopenia and consequently 
frailty. A multicomponent exercise training program, 
which includes aerobic, strength, and balance exercises, 
is considered to be the most effective tool for improving 
mobility and gait, increasing muscle mass and strength, 
decreasing falls, enhancing functional performance of 
activities of daily living, and improving quality of life.12
This article first summarizes the functional alterations 
occurring in the sarcopenic and frail population. In the 
second part, the article highlights opportunities and chal-
lenges to prevent functional impairment, and mobility 
impairment through a physical activity program based on 
randomized clinical trials: LIFE and SPRINTT. Finally, 
the article provides recommendations for maintaining and 
improving mobility and functional performance in this 
specific population.
Physiological Changes in the Older 
Population: Sarcopenia and/or 
Frailty
Muscle Strength and Power
In old age, the most important impact on mobility arises 
from changes in muscle strength and power. “Strength” 
can be defined as the maximum force generation capacity 
of an individual, whereas “power” refers to the product of 
force and velocity of contraction.13–15 Several studies have 
demonstrated that strength capacities start to decline 
around the age of 30 years16,17 and that the decline 
increases at the rate of about 12% to 15% per decade 
after the fifth decade, with an even faster decline after 60 
years.18 Longitudinal studies have reported that strength 
decreases about 2.5% and 1.5% per year after sixty years 
old at the knee and elbow joints, respectively.19 It has 
consequently been suggested that alteration of muscular 
strength could be muscle-specific.20,21 Skelton et al 
demonstrated that power declines with aging at an even 
more rapid rate than strength.15 The origins of strength and 
power decline with aging are multifactorial. In two 
reviews, Clark and Manini22 and Vandervoort23 character-
ized the loss of neuromuscular strength with aging. In 
these reviews, the authors reported that neuromuscular 
strength could be directly influenced by changes in both 
the nervous system and the muscular system. Regarding 
the nervous system, the authors indicated that alteration of 
command drive,24–31 spinal reflex excitability,32,33 and 
motor unit discharge rate34 can alter strength production 
in older people. In the muscular system, alterations were 
observed in muscle mass size,3,35 muscular architecture,36 
and excitation–contraction coupling,37 which can be influ-
enced by reduction of androgen secretion and growth 
factor.38,39 Studies over the last four decades have demon-
strated that physiological deficiencies are clearly asso-
ciated with functional performance.15,40-43
Related to physical function, there is evidence that knee 
extensor strength is an excellent predictor of dependency and 
survival, and that leg power is a stronger predictor of mobi-
lity loss than strength.40,44-46 Bean et al40 found that leg 
power was strongly predictive of physical performance in 
45 participants aged about 73 years (75% women), high-
lighting a significant relationship with stair climb time, 
chair stand, tandem gait time, habitual gait velocity, maximal 
gait velocity and Short Physical Performance Battery (SPPB) 
tests (Table 1). Other studies have reported that handgrip 
strength is strongly associated with lower limb muscle 
power and physical function of daily living.47,48 In conclu-
sion, it can be stated that muscle strength and power decline 
at different rates, with power decreasing more rapidly than 
strength. While many factors contribute to strength and 
power decline, muscle mass is of key importance.
Muscle Mass
As previously mentioned, the combination of low muscle 
strength, low physical performance, and reduction of 
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Table 1 Overview of Tests Available for the Assessment of Balance, Gait, and Lower Extremity Function
Tested 
Function
Name Description Interpretation
Balance 
Gait 
Lower 
extremity 
function
Short Physical 
Performance 
Battery (SPPB)179
The SPPB involves three subtasks: balance test, habitual gait 
speed, and the 5-repetition chair stand test. Possible scores 
range from 0 to 12. 
Balance test: 
Ability to stand for 10 seconds with feet in three different 
positions: 
- Side-by-side (scored from 0–1) 
- Semi-tandem (scored from 0–1) 
- Full-tandem (scored from 0–2) 
Gait speed test: 
Timed 4-min walk at usual pace: 
- 0, unable to do the walk 
- 1, if time is > 8.7 seconds 
- 2, if time is 6.21 to 8.70 seconds 
- 3, if time is 4.82 to 6.20 seconds 
- 4, if time is <4.82 seconds 
Chair stand test: 
Time to rise from a chair five times as quickly as possible: 
- 0, unable to complete five chair stands or completes stands 
in >60 seconds 
- 1, chair stand time is ≥ 16.70 seconds 
- 2, chair stand time is 13.70 to 16.69 seconds 
- 3, chair stand time is 11.20 to 13.69 seconds 
- 4, chair stand time is ≤ 11.19 seconds
Total balance test score: __/4 points 
Gait speed test score: __/4 points 
Chair stand test score: __/4 points 
Total score __/12 points 
(sum of points above) 
Score and classification of limitation: 
0–3: Severe 
4–6: Moderate 
7–9: Low 
10–12: Very low/absent
Balance 
Gait
Tinetti balance 
assessment 
tool180
The Tinetti balance assessment tool consists of balance and 
walking tests. Possible scores range from 0 to 28. 
Balance maneuvers assessment (eight items) 
- Sitting balance scored from 0–1 
- Rising from chair scored from 0–4 
- Immediate standing balance (first 5 seconds) scored from 
0–2 
- Prolonged standing balance scored from 0–2 
- Withstanding nudge on chest scored from 0–2 
- Standing balance with eyes closed scored from 0–1 
- Turning 360 degrees scored from 0–2 
- Sitting down scored from 0–1 
Gait observations assessment (eight items) 
- Initiation of gait scored from 0–2 
- Step length scored from 0–2 
- Step height scored from 0–2 
- Step continuity scored from 0–2 
- Step symmetry scored from 0–1 
- Walking stance scored from 0–1 
- Amount of trunk sway scored from 0–1 
- Path deviation scored from 0–2
Total balance test score: __/15 points 
Total gait test score: __/13 points 
Total score __/28 points 
(sum of points above) 
Score and risk of falls: 
<19: High 
19–23: Moderate 
>24: Low
Balance One-leg balance 
test181
The one-leg balance test assesses the ability to stand upright 
on one leg.
Score and risk of falls: 
<5 second: High 
6–29 seconds: Moderate 
>30 seconds: Low
(Continued)
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Table 1 (Continued). 
Tested 
Function
Name Description Interpretation
Balance Berg Balance 
Scale (BBS)182
The BBS tests balance function by assessing the performance 
of functional tasks. Possible scores range from 0 to 56. 
Assessments (14 items scored from 0–4) 
- Sitting to standing 
- Standing unsupported 
- Sitting with back unsupported but feet supported on floor 
or on a stool 
- Standing to sitting 
- Transfers 
- Standing unsupported with eyes closed 
- Standing unsupported with feet together 
- Reaching forward with outstretched arm while standing 
- Pick up an object from the floor from a standing position 
- Turning to look behind over left and right shoulders while 
standing 
- Turn 360 degrees 
- Place alternate foot on step or stool while standing 
unsupported 
- Standing unsupported one foot in front 
- Standing on one leg
Score and risk of falls: 
0–20: High 
21–40: Moderate 
41–56: Low 
A change of at least eight points indicates an 
actual change in function between two 
assessments.
Gait 
Lower 
extremity 
function
Timed Up and Go 
(TUG)183
TUG is used to assess mobility. 
Participant is instructed to rise from a chair, walk three 
meters, turn around a physical marker, walk back to the chair, 
and sit down.
Score and classification of mobility: 
<10 seconds: Normal 
10–20 seconds: Moderate 
20–30 seconds: Low 
>30 seconds: Very low
Gait 400-m walk 
test184
The 400-m walk test assesses mobility over a long track. 
Participant is instructed to walk at normal pace. The 400- 
meter path is materialized with two physical markers located 
20 meters apart. During the test, the participant may not use 
assistive devices (except for a cane). Criteria for interrupting 
the test are palpitations, chest pain, constriction, feeling of 
oppression, dyspnea, sensation of fainting, empty head, or 
postural instability, pain in the lower limbs, vertigo, and 
muscle fatigue. 
The 400-m walk time is measured using a manual 
chronometer or an optoelectronic system with two 
photocells connected to a digital chronometer.
Participant unable to complete the test within 
15 min is considered to be mobility disabled.
Gait 6-Minutes 
Walking Test (6- 
MWT)185
The 6-MWT assesses mobility and cardiorespiratory fitness. 
Participant is instructed to walk at brisk pace he/she can 
maintain throughout the test. The path is materialized with 
two physical markers located at 20 meters apart. During the 
test, the participant may not use assistive devices (except for 
a cane). Criteria for interrupting the test are palpitations, 
chest pain, constriction, feeling of oppression, dyspnea, 
sensation of fainting, empty head, or postural instability, pain 
in the lower limbs, vertigo, and muscle fatigue. 
The 6-MWT distance is calculated by the sum lap distance (40 
m per lap) plus the distance walked during the last lap.
Participant unable to complete at least 332 
meters (walking speed 0.8 m/s) is considered to 
be mobility disabled.
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muscle mass characterize sarcopenia.3–5,49 Sarcopenia is 
considered a critical point to determine the frail population 
and can be influenced by several factors. In a recent over-
view, Marzetti et al3 reported that sarcopenia can be 
impacted by (i) personal factors such as age, early life 
events, low birth weight, and genetic characteristics, (ii) 
hormonal factors (eg, testosterone, estrogens, growth hor-
mone, insulin-like growth factor-1), chronic low-grade 
inflammation, and mitochondrial dysfunction, (iii) lifestyle 
habits such as decrease in food and protein intake, seden-
tary behavior or reduced physical activity, alcohol abuse, 
tobacco use, and bed rest, (iv) chronic health conditions 
such as cognitive impairment, diabetes, and advanced 
stage organ diseases.
The literature has shown that after the seventh decade, 
muscle mass decreases by 4.7% and 3.7% per decade in 
men and women, respectively.14 Using dual energy X-ray 
absorptiometry (DXA) to examine muscle mass in 433 
individuals (180 women) aged 18–94 years, Kyle et al50 
reported that muscle mass is almost steady from 18 to 60 
years, and declines after 60 years. In a magnetic resonance 
imagery (MRI) study in 468 individuals (200 women), 
Janssen et al51 also reported that the rate of loss of muscle 
mass of upper limbs decreases less than twice the rate of 
loss of lower limbs. Further, men showed larger age- 
related muscle mass decrease compared to women.52
Muscle mass can be estimated with several techniques 
such as anthropometric measurements, bioelectrical impe-
dance analysis (BIA), computed tomography (CT), MRI, 
and DXA. Each of these techniques has advantages and 
disadvantages in terms of cost, availability, ease of use and 
time consumption.3 Compared to the gold standard for 
quantifying muscle mass, ie CT and MRI, DXA may, 
due to the minimal radiation received by the patient, be 
the best way of differentiating fat and lean tissues. 
However, DXA scan is not portable, which limits its use 
in a large-scale population. To overcome this issue, BIA is 
inexpensive, easy to perform, readily reproducible, appro-
priate for ambulatory as well as bedridden patients, and 
more accurate than anthropometry. All in all, DXA could 
be considered as the best gold standard alternative to 
quantify muscle mass in research, and BIA as a valid 
portable alternative.
While the relationship between muscle mass decline 
and negative outcomes is still debated in the literature,14 
recent studies provide robust evidence that sarcopenia, 
including loss of muscle mass, is associated with falls, 
physical frailty, and disability.3 Older adults with 
sarcopenia are reportedly less active than people without 
sarcopenia.53,54 Furthermore, different studies have shown 
that the older population with sarcopenia has a greater risk 
of death (whatever the causes) compared with nonsarco-
penic people.55–59 From another perspective, the decrease 
in the circulating levels of specific hormones has been 
associated with both sarcopenia and osteoporosis, showing 
that the two processes follow a similar path.60 An observa-
tional study recently carried out among 68 prefrail older 
persons aged between 65 and 95 years reported that those 
with osteosarcopenia were at higher risk of fractures or 
functional decline than those with either sarcopenia or 
osteoporosis.61 Further, the authors showed that the per-
formance on the handgrip strength, chair rise and sit-to- 
stand tests were significantly lower in patients with osteo-
sarcopenia than in those with sarcopenia or osteoporosis 
alone. Finally, it has been reported that the sarcopenic 
older population was more than threefold likely to fall 
than those without sarcopenia.62–64
Balance and Postural Control
It has been well documented that postural control decreases 
and risk of falls increases with aging. As a result, falls are a 
common event in older adults, with about one third of persons 
65 years and older experiencing a fall event yearly. This 
number increases to nearly 50% in the age group 80 years 
and above.65 The decline in balance and postural control are 
multicausal. To maintain upright standing, the neuromuscular 
system has to generate appropriate muscular contraction invol-
ving complementary input from the visual, proprioceptive, 
exteroceptive and vestibular systems.66–71 Age-related altera-
tion in these different systems results in decline of postural 
control.72–74 Experimental studies have shown that older per-
sons are less able to regulate postural control when sensory 
information is manipulated or removed.72,74–76 In a challen-
ging condition, such as one-leg stance, maintaining upright 
standing is more energy-consuming in older than in their 
young counterparts.77–79 Strength capacity is also useful to 
discriminate fallers from nonfallers, showing that the former 
group is weaker than the latter.80 It has also been shown that 
aging is associated with a progressive shift from spinal to 
supraspinal pathways to regulate leg muscle activity in an 
upright standing position.81 This finding is supported by 
experimental studies reporting that the frail population could 
require more cognitive resources to maintain upright standing, 
and consequently increase the delay of postural control adjust-
ment in comparison with healthy older adults.82–84 While there 
is no clear evidence of specific system alteration between frail 
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and nonfrail, and sarcopenia vs nonsarcopenia populations, 
clinical studies have shown more conclusive results.
From a meta-analysis, Yeung et al85 recently reported 
significant higher risk of falls in people with sarcopenia 
than without. Further, in a systematic review and meta-ana-
lysis of 10 studies with 10,073 participants, Zhang et al86 
concluded that sarcopenia is a risk factor for falls among 
community-dwelling older people, but not in nursing home 
residents. The authors provided several explanations for this 
counterintuitive finding.87,88 First, nursing-home residents 
may have limited mobility due to their poorer health status, 
which may moderate the effect of sarcopenia on falls.89 In 
addition, in community-dwelling older adults falls were 
reported with questionnaires, whereas falls in nursing 
homes reported by nurses may be underestimated. With 
regard to gender, Zhang et al86 indicated that old men with 
sarcopenia had a higher risk of falls than older persons in 
mixed gender groups. These results are supported by the fact 
that muscle mass decreases in men are generally twice as 
great than in women.90,91 In addition to sarcopenia, a sys-
tematic review and meta-analysis by Kojima92 demonstrated 
that both frailty and prefrailty are significant predictors of 
future falls among community-dwelling older people. This 
could result from decreased functional reserve capacity in 
multiple physiologic systems and increased vulnerability to 
stressors such as accidents, disease symptoms, or adverse 
drug reactions.93 All in all, the literature has demonstrated 
an age-related increased risk of falls, especially in persons 
with sarcopenia and the frail population. The increased risk 
of falls with aging is intrinsically linked to the deterioration 
of the dynamic balance generated during walking and, more 
generally, when in relation to mobility.
Walking and Mobility
Locomotion, defined as a motor action that changes the 
location of the entire body within the environment, is a 
common daily activity in human beings. Walking speed, 
representing the capacity of walking, declines slightly 
until the sixth decade, and decreases at a faster pace 
thereafter.9,94,95 In a cross-sectional study, Samson et al95 
evaluated the preferred walking speed over a 12-meter 
walkway in 118 women and 121 men aged from 19 to 90 
years. The authors found an age-related decrease of gait 
parameters with an alternation not only in walking speed, 
but also in stride length. However, modification of walking 
patterns with age has not appeared consistently throughout 
the literature. Compared to young adults, some studies have 
reported greater stride width in older adults,96–98 while 
other studies have indicated lesser stride width with older 
age.99 Ko et al100 revealed that stride width at preferred 
walking speed was narrower in middle-age (32–57 years) 
than in old adults (58–78 years) at maximum speed, while it 
was wider in oldest old group (79–93 years). The authors 
concluded that the walking pattern alteration could be dif-
ferent during the aging process, and could also depend on 
testing conditions. The impact of the methods used to obtain 
walking/gait speed was also addressed by Ng et al101 and 
Wang et al102 To explain alterations of walking capacity and 
patterns, different hypotheses have been put forward. In the 
Baltimore Longitudinal Study of Aging, a significant corre-
lation between walking speed and maximal voluntary con-
traction of knee extensor was shown.100 The authors’ 
interpretation was that a decrease of knee extensor muscle 
strength could explain the decline of walking speed with 
aging. Callisaya et al103 found an association among white 
matter atrophy and walking speed, step length and cadence. 
The authors suggested that these results strengthened the 
evidence of a causal relationship between brain aging and 
walking decline. In a recent systematic review and meta- 
analysis, Peel et al104 supported these results by reporting 
an association between gait speed performance and global 
cognitive function in community-dwelling older people 
throughout 16 longitudinal (15,662 participants) and 20 
cross-sectional (13,848 participants) studies. This meta-ana-
lysis showed reduction of gait speed of 0.11 m/s in persons 
with cognitive impairment, 0.20 m/s in those with mild 
dementia, and of 0.41 m/s in those with moderate dementia, 
compared to cognitively intact older adults. In addition to 
cognitive functions, walking speed may be related to older 
people’s mobility.
While 85% of people at the age of 60 years have a 
normal gait, this proportion drops to 18% in people aged 85 
years. In a predictive model study, Guralnik et al179 reported 
that walking speed is a good predictor of daily living 
activity disability and mobility impairment. Furthermore, 
age-related walking speed decline has been associated 
with increased risk of falls,105 quality of life,106 health 
status,107 physical function, and mobility,108,109 cognitive 
decline and dementia,110–112 and early mortality.113 More 
specifically, Studenski et al113 using individual data from 
34,485 community-dwelling older adults (from nine cohort 
studies) with a follow-up longer than five years, evaluated 
the relationship between gait speed and survival. The 
authors reported that survival increases across the full 
range of gait speeds, with a gait speed of around 0.8 m/s 
at the median life expectancy at most ages for both sexes. 
Billot et al                                                                                                                                                             Dovepress
submit your manuscript | www.dovepress.com                                                                                                                                                                                                                    
DovePress                                                                                                                                                     
Clinical Interventions in Aging 2020:15 1680
They reported that gait speed, adjusted by age and sex, 
provided as accurate as predictions based on age, sex, use 
of mobility aids, and self-reported function or as predictions 
based on age, sex, chronic conditions, smoking history, 
blood pressure, body mass index, and hospitalization. All 
in all, the authors suggested that gait speed could be used in 
a simple way as an indicator of the health of older persons, 
and might help to identify populations that could benefit 
from preventive intervention. For all these reasons, walking 
speed has been identified as the sixth vital sign in geriatric 
assessment,114 and could be the main indicator of mobility 
loss in the older population. In addition to motor function 
impairment, aging has an impact at the molecular and 
cellular level.
Molecular and Cellular Factors
Aging is accompanied by changes in molecular, cellular and 
organ level and modulated by genetic, behavioral and envir-
onmental factors. One of the most important factors in this 
area is the immune dysregulation producing high blood levels 
of pro-inflammatory immunogenetic stimulation.115 High 
levels of circulating pro-inflammatory markers, eg Il-1, IL-6 
as well as C-reactive protein, transforming growth factor ß and 
others are responsible for immune dysregulation and increased 
inflammation in older age. This pro-inflammatory status is 
often known as “inflammaging”.115 Epidemiological studies 
have demonstrated the negative impact of inflammaging on 
cardiovascular disease, neurological disorder such as depres-
sion or dementia, and furthermore on global health indicators 
such as frailty, sarcopenia, and mobility limitation.115
There is increasing evidence that low physical activity 
levels increases the accumulation of visceral fat, adipose 
infiltration by pro-inflammatory immune cells and persis-
tent low-grade inflammation.116 In his review article 
Philipps117 provided evidence that long-term physical 
activity modulates age-related cellular and molecular 
changes. Physical activity has a positive impact on the 
inflammatory processes and increases the resilience stress 
response.117
Given that aging induces alterations in strength and 
power, muscle mass, balance and postural control, walking 
and mobility, physical activity or an exercise program 
provide opportunities to reduce and/or to stave off some 
of the negative effects of aging.
Opportunities
Evidence suggests that regular physical activity provides 
substantial health benefits and reduces risk of chronic 
diseases. In a systematic review, Paterson and 
Warburton118 demonstrated that inactive older persons 
ran an increased risk of functional limitations. 
Interestingly, the risk of physical limitations decreased on 
average about 20% if the person was only “somewhat 
active” (level 1 of physical activity). Moderate physical 
activity reduced even further the risk of functional limita-
tions. It is commonly understood that any type of physical 
activity, even at low intensity, is one of the most effective 
strategies designed to counteract the onset of chronic dis-
eases, eg Type II diabetes and cardiovascular disease,119 
and to support healthy aging. In addition, physical activity 
decreases mobility limitations, and supports independent 
status as well as quality of life.120 Taylor119 stated that 
physical activity should be regarded as an actual “medi-
cine” due to its large array of health benefits. Hence, 
several recommendations for older persons to be physi-
cally active have been published.121–123 These recommen-
dations propose similar advice: an older person should be 
physically active for about 30 min per day adding up to 
150 min per week of moderate physical activity. One has 
to keep in mind that the term “physical activity” incorpo-
rates all movements that increase energy expenditure. 
Another important point in all of the recommendations 
addresses the intensity level by proposing moderate or 
even vigorous levels of physical activity, and the inclusion 
of strength and balance exercises.121,122 With regard to 
intensity, brisk walking may be considered as moderate 
and running or jogging as vigorous physical activity.122 
Nevertheless, most older adults rarely reach moderate-to- 
vigorous intensity on a daily basis and walking at light 
intensity constitutes the major part of physical activity in 
which they engage.124 Knowing that additional health 
effects arise from engaging in a higher level of physical 
activity, especially in structured exercise programs,119,121 
greater efforts should be made to increase the participation 
of older adults.
With regard to function, a recent review by Steffl et al54 
demonstrated that physical activity also has positive effects 
on physical function, eg modifying the sarcopenic process. 
This is in line with the findings by Marzetti et al125 With 
regard to cognitive function, evidence is evolving that phy-
sical activity and exercise also have positive effects on 
cognitive capacities such as memory, attention, or executive 
function. Although the effects of physical activity on cog-
nitive function vary with regard to physical activity mod-
ality (aerobic, strength, or other type), intensity (light, 
moderate, or vigorous), and various cognitive domains, 
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evidence exists that older persons benefit from physical 
activity or exercise training with regard to cognitive func-
tions and in some cases maintain this benefit over the long- 
term.126–130
With regard to the important issue of fall events in 
older persons, recent reviews have underlined the impor-
tance of targeted, planned, and structured exercise inter-
vention including progressive strength training and 
challenging balance exercise.131,132 It is important to rea-
lize that in fall prevention the subcategory of exercise, not 
the broad-based term of physical activity, has demon-
strated positive effects.
Over recent years another construct has been recog-
nized as a key factor: sedentary behavior, which has been 
found to be an important risk factor for adverse events in 
older adults. In an EU project, the determinants of seden-
tary behavior were defined over the life span, and espe-
cially in older persons.133 Sedentary behavior, or the 
formal construct of inactivity, has not only demonstrated 
negative health impact on an individual level, but has also 
generated deleterious economic and social consequences. 
Inactivity was responsible for about 5.3 to 5.7 million 
deaths globally from noncommunicable diseases, which 
could be prevented if people who were inactive were 
instead sufficiently active.134 These findings are indepen-
dent of physical activity levels.135 Not surprisingly, in 
most recommendations reduction of sedentary behavior 
has been included, with the goal of reducing sitting time.-
122 Several studies have demonstrated the negative health 
impact of sedentary behavior.133,136 Nevertheless, recent 
research has demonstrated that although replacing seden-
tary behavior with moderate-to-vigorous physical activity 
is associated with reduction of sarcopenia rates and with 
better performance across its determinants in a dose- 
response fashion, light physical activity also seemed 
protective.137
In conclusion, these results suggest that even light 
physical activity, in which most older adults can partake, 
could contribute to healthy aging, by counteracting one of 
the most important contributors to functional loss, 
sarcopenia.138 It is evident that physical activity has 
demonstrated beneficial health effects in older persons, 
whereas the other side of the coin—sedentary behavior— 
has only lately been recognized as equally important. 
Further research has demonstrated the positive effects of 
even a small increase in physical activity levels on health 
outcomes.139 While regular physical activity offers clear 
opportunities to improve health, many challenges are 
encountered by the older population.
Challenges
Older persons constitute the most inactive cohort in popula-
tion-based studies.140,141 In Australia, among persons aged 
75 years and older, about 75% are reported not to meet 
recommended physical activity levels.140 Older persons’ 
motivation to engage in physical activity is influenced by 
behavioral (eg perceptions, self-efficacy) and environmental 
factors (eg access, availability). Furthermore, different 
domains add to the complexity of engaging older persons 
in physical activity: type and intensity of physical activity, 
group or individual physical activity, organizational issues 
(morning or afternoon).120,140 The need to communicate 
and translate research findings on the positive effects of 
physical activity has been recognized lately by investigating 
the perception of older persons. Communication models 
such as the elaboration likelihood model (ELM) by Petty 
and Cacioppo142 or behavior-related psychological models 
such as the health belief model (HBM) or integrated beha-
vior change model (ICBM) have been used. Most models of 
increased physical activity share as a central point self- 
efficacy, norms and values, as well as attitudes.143 Being 
“too old” or “at my age, physical activity does not help” are 
attitudes that pose a barrier to adhering to physical activity 
recommendations.144,145 Low self-efficacy likewise poses a 
barrier for uptake or maintenance of physical activity or 
exercise programs.146 Taking into account the specificities 
of the two domains, it is of utmost importance to phrase 
invitations in a positive manner and to address older per-
sons’ perceptions of physical activity. In other words, older 
persons or future participants in research projects on exer-
cise intervention should be persuaded that they are able to 
take part or carry out the proposed physical activity.147
Several factors that prevent older persons from being 
physically active have been reported. In a systematic 
review, Baert et al148 provided a theoretical framework 
for investigating barriers to physical activity in older 
adults. The social-ecological model used in this systematic 
review provides different levels to be addressed when 
investigating these barriers.148 The model differentiates 
intrapersonal, interpersonal, community, and policy-based 
barriers. A similar differentiation method was used by 
Bauman et al149 who also identified interpersonal, intra-
personal and extrapersonal factors such as environment 
and policy. On an intrapersonal level, for example, several 
factors have been identified as barriers. Baert et al148 
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identified health status as a barrier for physical activity, 
which is in line with the findings of Newson and Kemps150 
and Lubs et al151 However, health status can act as an 
enabler and motivation to become physically active and 
thereby improve health outcomes.152,153
Further expertise to an increased level of physical 
activity or exercise programs may be found in the fall 
prevention research field.154–157 Elskamp et al154 detected, 
on an individual level, the following reported reasons for 
nonactivity: lack of time, impaired mobility or “being too 
healthy”. Furthermore, one study showed that fall risk 
perception was related to fear of vulnerability, mainte-
nance of autonomy, and interpretation of risk.158
In conclusion, increasing physical activity or uptake of 
exercise intervention in older persons is a challenging and 
complex task. Several aspects of theoretical psychological 
models need to be taken into account, and positive word-
ing as well as the highlighting of positive outcomes are of 
utmost importance in strengthening older persons’ belief 
that they can perform or take part in the proposed activity 
to follow the recommendations.
Recommendations and Procedures
Due to current demographic trends, health promotion and 
physical independence are crucial. The most recent recom-
mendations advise aging people, frail or not, to perform a 
minimum of 30 min of moderate intensity physical activity 
such as fast pace walking, at least five days per week 
(Figure 1).159 Further, in a meta-analysis of more than 
one million men and women, Ekelund et al160 reported 
that a high level of physical activity, equivalent to 60–75 
min of moderate intensity per day, seemed to offset the 
increased mortality risk associated with prolonged sitting 
time. More specifically, the study found that the active 
older persons (about 60–75 min/day) who sit for more 
than eight hours daily have a significantly lower risk of 
mortality than people who sit for less than four hours per 
day with less physical activity (about five min/day). Based 
on these findings, physical activity can cancel out the 
deleterious effect of inactivity and be justified in older 
persons. To date, the largest and longest study on physical 
activity in the older population is the Lifestyle 
Interventions and Independence for Elders (LIFE) recently 
conducted in the US.12 This multicenter randomized con-
trolled trial (RCT) assessed the efficacy of a structured 
exercise program (designated by the authors as a physical 
activity program) compared to an educational group in 
preventing disability in 1635 sedentary and functionally 
limited persons older than 70 years, over a follow-up 
period of 2.6 years. In the LIFE study, physical interven-
tion was based on a combination of walking (with a goal 
of 150 min/week), strength, flexibility and balance exer-
cises at the center twice per week and at home once per 
week (weeks 1–4), twice per week (4–8 weeks) and up to 
four times per week (week 8–52). The exercise sessions 
were individualized, setting an overall target of 30 min at 
moderate intensity, 10 min of strength training of lower 
limbs, 10 min of balance training, and flexibility exercises. 
This study demonstrated that compared with a health edu-
cation program, a structured moderate-intensity exercise 
program reduced major mobility disability, persistent 
mobility disability and a combined outcome of major 
mobility disability or death over 2.6 years of follow-up.
Although no final results are available of the SPRINTT 
study yet, initial experiences in the challenges of recruit-
ment in such a population have been reported161 after the 
study protocol had been published.162 The SPRINTT 
study, a phase III, single-blind, multicenter RCT was 
designed to compare the efficacy of a multicomponent 
intervention (MCI) program (exercise intervention, nutri-
tional counseling/dietary intervention, and information and 
communication technology intervention) versus a Healthy 
Aging Lifestyle Education (HALE) program in prevention 
of mobility impairment in initially nondisabled older per-
sons with physical frailty and sarcopenia.162 Emphasizing 
a combination of physical activity/exercise and nutritional 
intervention, the SPRINTT RCT differs from the LIFE 
study.161 The MCI program was based on the exercise 
protocol of the LIFE study12 and consists of aerobic, 
strength, flexibility, and balance training.12,163 The physi-
cal activity/exercise program was designed to be per-
formed both at the center (twice a week with an 
instructor) and at home (3–4 times/week).125 As the pri-
mary goal is to enhance mobility, strength training inter-
vention is mainly focused on lower extremity exercises, 
while upper body exercises are carried out at the end of the 
training session.
Nutrition is a major determinant of muscle health, 
physical function and overall well-being, especially in 
older persons.164–166 It follows that nutrition may play a 
role as a part of multicomponent interventions aimed at 
preserving muscle mass, counteracting physical perfor-
mance decline and promoting robustness.164,167,168 In 
this context, it is widely acknowledged that a combina-
tion of nutrition and exercise programs is one valuable 
approach to management of sarcopenia and the physical 
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components of frailty.164 Nutritional patterns conveying 
adequate daily energy, protein, as well as micronutrients 
(eg vitamins and plant-derived antioxidants), dietary 
fiber and healthy oils (in particular extra-virgin olive 
oil) have shown positive effects on muscle mass, phy-
sical function preservation and overall metabolic 
health.169–172 Several strategies may be implemented to 
design a nutritional plan for older adults involved in 
physical activity interventions aimed at maximizing the 
benefits of training and overcoming the traditional 
barriers that hamper its deployment in real life (ie lack 
of motivation, low adherence).173,174
In the SPRINTT RCT, a multifactorial approach was 
developed combining a physiologic/metabolic rationale 
with the educational/behavioral aspects of nutrition. The 
nutritional intervention of SPRINTT was designed to provide 
adequate quality and quantity of macro- and micronutrients 
tailored to the individual’s age, gender, health status, physical 
performance levels, comorbidities and therapies.162 
Individual preferences as well as a constant and timely 
Figure 1 A Schematic representation summarizes the opportunities, the challenges, the recommendation of physical activity intervention to preserve mobility in older 
adults with physical frailty and sarcopenia.
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dialogue between participants and nutritional “trainers” was 
implemented throughout the trial to increase adherence, 
motivation and nutritional awareness in older persons.162 
Two predefined nutritional targets were set according to 
expert recommendations: (1) a daily total energy intake of 
25–30 kcal/kg body weight (corrected by ideal weight when 
appropriate); and (2) an average protein daily intake of at 
least 1.0–1.2 g/kg body weight.175–177 Vitamin D levels were 
also regularly monitored and supplementation was pre-
scribed if serum concentrations of 25-hydroxyvitamin D 
(25-OH-D) were below 30 ng/mL (75 nmol/L).178
Conclusion
Aging induces biological and functional decline at several 
levels: loss of muscle strength, loss of muscle mass, 
decline in balance, and subsequent loss of mobility. 
Sarcopenia and more widely frailty are critical points to 
address in preventive physical activity/exercise programs 
to avoid loss of mobility and physical performance. 
Physical activity and nutritional support to improve phy-
sical function and to prevent sarcopenia, frailty and dis-
ability are widely recommended in the literature. While 
the efficacy of long-term physical activity/exercise pro-
grams is to date available only in the LIFE study con-
ducted in the US,12 the SPRINTT study will provide new 
evidence of physical activity program feasibility and effi-
cacy to prevent mobility impairment among sarcopenic 
and physically frail older adults.
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